Neuroactive steroids, their metabolites, and neuroinflammation

Journal of Molecular Endocrinology

Volumn 49, Issue 3, 2012, Pages

  Giatti, Silvia ^a   Boraso, Mariaserena ^a   Melcangi, Roberto Cosimo ^a   Viviani, Barbara ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

20ALPHA DIHYDROPROGESTERONE; ANDROGEN RECEPTOR; ANDROSTENEDIOL; DRUG METABOLITE; ESTROGEN; LEVODOPA; NEUROACTIVE STEROID; NEUROSTEROID; PRASTERONE; PROGESTERONE; TESTOSTERONE; TETRAHYDROPROGESTERONE; UNCLASSIFIED DRUG;

AGING; ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; BLOOD BRAIN BARRIER; CYTOKINE RELEASE; HUMAN; METABOLITE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STEROID METABOLISM; STEROIDOGENESIS; TRAUMATIC BRAIN INJURY;

ANDROGENS; ANIMALS; ESTROGENS; HUMANS; INFLAMMATION; NERVOUS SYSTEM; PROGESTINS; STEROIDS;

EID: 84867916090     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0127     Document Type: Review

References (100)

1. Alam S, Laughton DL, Walding A & Wolstenholme AJ 2006 Human peripheral blood mononuclear cells express GABAA receptor subunits. Molecular Immunology 43 1432-1442. (doi:10.1016/ j.molimm.2005.07.025)
2. Arevalo MA, Santos-Galindo M, Acaz-Fonseca E, Azcoitia I & Garcia-Segura LM 2012 Gonadal hormones and the control of reactive gliosis. Hormones and Behavior. In press. (doi:10.1016/ j.yhbeh.2012.02.021)
3. Barreto G, Veiga S, Azcoitia I, Garcia-Segura LM & Garcia-Ovejero D 2007 Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. European Journal of Neuroscience 25 3039-3046. (doi:10.1111/j.1460-9568.2007.05563.x)
4. Baulieu EE 1998 Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 963-987.
5. Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA & Offner H 2001 Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. Journal of Immunology 166 2080-2089.
6. Belelli D & Lambert JJ 2005 Neurosteroids: endogenous regulators of the GABA(A) receptor. Nature Reviews. Neuroscience 6 565-575. (doi:10.1038/nrn1703)
7. Benarroch EE 2005 Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clinic Proceedings 80 1326-1338. (doi:10.4065/80.10.1326)
8. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW & Steinman L 2010 Inhibitory role for GABA in autoimmune inflammation. PNAS 107 2580-2585. (doi:10.1073/pnas.0915139107)
9. Block ML, Zecca L & Hong JS 2007 Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews. Neuroscience 8 57-69. (doi:10.1038/nrn2038)
10. Brinton RD & Wang JM 2006 Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Current Alzheimer Research 3 185-190. (doi:10.2174/156720506777632817)
11. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ et al. 2008 Progesterone receptors: form and function in brain. Frontiers in Neuroendocrinology 29 313-339. (doi:10.1016/j.yfrne.2008.02.001)
12. Caruso D, Scurati S, Maschi O, De Angelis L, Roglio I, Giatti S, Garcia-Segura LM & Melcangi RC 2008 Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochemistry International 52 560-568. (doi:10.1016/j.neuint.2007. 06.004)
13. Caruso D, D'Intino G, Giatti S, Maschi O, Pesaresi M, Calabrese D, Garcia-Segura LM, Calza L & Melcangi RC 2010 Sex-dimorphic changes in neuroactive steroid levels after chronic experimental autoimmune encephalomyelitis. Journal of Neurochemistry 114 921-932. (doi:10.1111/j.1471-4159.2010.06825.x)
14. Cho BP, Song DY, Sugama S, Shin DH, Shimizu Y, Kim SS, Kim YS & Joh TH 2006 Pathological dynamics of activated microglia following medial forebrain bundle transection. Glia 53 92-102. (doi:10.1002/ glia.20265)
15. Ciriza I, Azcoitia I & Garcia-Segura LM 2004 Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. Journal of Neuroendocrinology 16 58-63. (doi:10.1111/j.1365-2826.2004.01121.x)
16. Ciriza I, Carrero P, Frye CA & Garcia-Segura LM 2006 Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. Journal of Neurobiology 66 916-928. (doi:10.1002/neu.20293)
17. Czlonkowska A & Kurkowska-Jastrzebska I 2011 Inflammation and gliosis in neurological diseases-clinical implications. Journal of Neuroimmunology 231 78-85. (doi:10.1016/j.jneuroim.2010.09.020)
18. Dalal M, Kim S & Voskuhl RR 1997 Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. Journal of Immunology 159 3-6.
19. Djebaili M, Hoffman SW & Stein DG 2004 Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 123 349-359. (doi:10.1016/j.neuroscience.2003.09.023)
20. DonCarlos LL, Sarkey S, Lorenz B, Azcoitia I, Garcia-Ovejero D, Huppenbauer C & Garcia-Segura LM 2006 Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience 138 801-807. (doi:10.1016/j.neuroscience. 2005.06.020)
21. Farina C, Aloisi F & Meinl E 2007 Astrocytes are active players in cerebral innate immunity. Trends in Immunology 28 138-145. (doi:10.1016/j.it.2007.01.005)
22. Feeser VR & Loria RM 2011 Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. Journal of Neuroimmunology 237 4-12. (doi:10.1016/j. jneuroim.2011.06.007)
23. Garay L, Tungler V, Deniselle MC, Lima A, Roig P & De Nicola AF 2011 Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience 192 588-597. (doi:10.1016/j.neuroscience.2011.06.065)
24. Garcia-Estrada J, Del Rio JA, Luquin S, Soriano E & Garcia-Segura LM 1993 Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Research 628 271-278. (doi:10.1016/0006-8993(93)90964-O)
25. Garci{dotless}́a-Ovejero D, Veiga S, Garci{dotless}́a-Segura LM & Doncarlos LL 2002 Glial expression of estrogen and androgen receptors after rat brain injury. Journal of Comparative Neurology 450 256-271. (doi:10.1002/ cne.10325)
26. Garcia-Segura LM & Balthazart J 2009 Steroids and neuroprotection: new advances. Frontiers in Neuroendocrinology 30 v-ix. (doi:10.1016/ j.yfrne.2009.04.006)
27. Garcia-Segura LM &Melcangi RC 2006 Steroids and glial cell function. Glia 54 485-498. (doi:10.1002/glia.20404)
28. Garcia-Segura LM, Veiga S, Sierra A, Melcangi RC & Azcoitia I 2003 Aromatase: a neuroprotective enzyme. Progress in Neurobiology 71 31-41. (doi:10.1016/j.pneurobio.2003.09.005)
29. Ghoumari AM, Ibanez C, El-Etr M, Leclerc P, Eychenne B, O'Malley BW, Baulieu EE & Schumacher M 2003 Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. Journal of Neurochemistry 86 848-859. (doi:10.1046/j.1471-4159.2003.01881.x)
30. Giachino C, Galbiati M, Fasolo A, Peretto P & Melcangi RC 2003 Neurogenesis in the subependymal layer of the adult rat: a role for neuroactive derivatives of progesterone. Annals of the New York Academy of Sciences 1007 335-339. (doi:10.1196/annals.1286.032)
31. Giachino C, Galbiati M, Fasolo A, Peretto P & Melcangi RC 2004 Effects of progesterone derivatives, dihydroprogesterone and tetrahydroprogesterone, on the subependymal layer of the adult rat. Journal of Neurobiology 58 493-502. (doi:10.1002/neu.10290)
32. Giatti S, D'Intino G, Maschi O, Pesaresi M, Garcia-Segura LM, Calza L, Caruso D & Melcangi RC 2010 Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochemistry International 56 118-127. (doi:10.1016/ j.neuint.2009.09.009)
33. Giatti S, Caruso D, Boraso M, Abbiati F, Ballarini E, Calabrese D, Pesaresi M, Rigolio R, Santos-Galindo M, Viviani B et al. 2012 Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis. Journal of Neuroendocrinology 24 851-861. (doi:10.1111/j.1365-2826.2012.02284.x)
34. Gibson CL, Gray LJ, Bath PM & Murphy SP 2008 Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131 318-328. (doi:10.1093/brain/awm183)
35. Glass CK, Saijo K, Winner B, Marchetto MC & Gage FH 2010 Mechanisms underlying inflammation in neurodegeneration. Cell 140 918-934. (doi:10.1016/j.cell.2010.02.016)
36. Gottfried-Blackmore A, Sierra A, Jellinck PH, McEwen BS & Bulloch K 2008 Brain microglia express steroid-converting enzymes in the mouse. Journal of Steroid Biochemistry and Molecular Biology 109 96-107. (doi:10.1016/j.jsbmb.2007.12.013)
37. Grossman KJ, Goss CW& Stein DG 2004 Effects of progesterone on the inflammatory response to brain injury in the rat. Brain Research 1008 29-39. (doi:10.1016/j.brainres.2004.02.022)
38. Hanisch UK & Kettenmann H 2007 Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience 10 1387-1394. (doi:10.1038/nn1997)
39. He J, Evans CO, Hoffman SW, Oyesiku NM & Stein DG 2004 Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Experimental Neurology 189 404-412. (doi:10.1016/j.expneurol.2004.06.008)
40. Hughes GC 2012 Progesterone and autoimmune disease. Autoimmunity Reviews 11 A502-A514. (doi:10.1016/j.autrev.2011.12.003)
41. Ishrat T, Sayeed I, Atif F, Hua F & Stein DGCP 2010 Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Experimental Neurology 226 183-190. (doi:10.1016/j.expneurol.2010.08.023)
42. Jellinck PH, Kaufmann M, Gottfried-Blackmore A, Croft G, Byford V, McEwen BS, Jones G & Bulloch K 2006 Dehydroepiandrosterone (DHEA) metabolism in the brain: identification by liquid chromatography/mass spectrometry of the delta-4-isomer of DHEA and related steroids formed from androstenedione by mouse BV2 microglia. Journal of Steroid Biochemistry and Molecular Biology 98 41-47. (doi:10.1016/j.jsbmb.2005.07.006)
43. Jellinck PH, Kaufmann M, Gottfried-Blackmore A, McEwen BS, Jones G & Bulloch K 2007 Selective conversion by microglia of dehydroepiandrosterone to 5-androstenediol-A steroid with inherent estrogenic properties. Journal of Steroid Biochemistry and Molecular Biology 107 156-162. (doi:10.1016/j. jsbmb.2007.04.004)
44. Jiang C, Cui K, Wang J & He Y 2011 Microglia and cyclooxygenase-2: possible therapeutic targets of progesterone for stroke. International Immunopharmacology 11 1925-1931. (doi:10.1016/j.intimp. 2011.08.001)
45. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B & Prat A 2007 Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Medicine 13 1173-1175. (doi:10.1038/nm1651)
46. Kipp M, Amor S, Krauth R & Beyer C 2012 Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender. Frontiers in Neuroendocrinology 33 1-16. (doi:10.1016/j.yfrne. 2012.01.001)
47. Labombarda F, Pianos A, Liere P, Eychenne B, Gonzalez S, Cambourg A, De Nicola AF, Schumacher M & Guennoun R 2006 Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology 147 1847-1859. (doi:10.1210/en.2005-0955)
48. Labombarda F, Gonzalez S, Lima A, Roig P, Guennoun R, Schumacher M & De Nicola AF 2011 Progesterone attenuates astro-and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Experimental Neurology 231 135-146. (doi:10.1016/j.expneurol.2011.06.001)
49. Lambert JJ, Belelli D, Peden DR, Vardy AW & Peters JA 2003 Neurosteroid modulation of GABAA receptors. Progress in Neurobiology 71 67-80. (doi:10.1016/j.pneurobio.2003.09.001)
50. Lavaque E, Mayen A, Azcoitia I, Tena-Sempere M & Garcia-Segura LM 2006a Sex differences, developmental changes, response to injury and cAMP regulation of the mRNA levels of steroidogenic acute regulatory protein, cytochrome p450scc, and aromatase in the olivocerebellar system. Journal of Neurobiology 66 308-318. (doi:10.1002/neu.20221)
51. Lavaque E, Sierra A, Azcoitia I & Garcia-Segura LM 2006b Steroidogenic acute regulatory protein in the brain. Neuroscience 138 741-747. (doi:10.1016/j.neuroscience.2005.05.060)
52. Lee M, Schwab C & McGeer PL 2011 Astrocytes are GABAergic cells that modulate microglial activity. Glia 59 152-165. (doi:10.1002/ glia.21087)
53. Liao H, Bu WY, Wang TH, Ahmed S & Xiao ZC 2005 Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function. Journal of Biological Chemistry 280 8316-8323. (doi:10.1074/jbc.M412730200)
54. Liew FY 2002 T(H)1 and T(H)2 cells: a historical perspective. Nature Reviews. Immunology 2 55-60. (doi:10.1038/nri705)
55. Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL & Hong JS 2002 Role of nitric oxide in inflammation-mediated neurodegeneration. Annals of the New York Academy of Sciences 962 318-331. (doi:10.1111/ j.1749-6632.2002.tb04077.x)
56. Luchetti S, Bossers K, Van de Bilt S, Agrapart V, Morales RR, Frajese GV & Swaab DF 2011a Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease. Neurobiology of Aging 32 1964-1976. (doi:10.1016/j.neurobiolaging.2009.12.014)
57. Luchetti S, Huitinga I & Swaab DF 2011b Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 191 6-21. (doi:10.1016/j.neuroscience. 2011.04.010)
58. Meffre D, Pianos A, Liere P, Eychenne B, Cambourg A, Schumacher M, Stein DG & Guennoun R 2007 Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148 2505-2517. (doi:10.1210/en.2006-1678)
59. Melcangi RC & Garcia-Segura LM 2010 Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Hormones and Behavior 57 2-11. (doi:10.1016/j.yhbeh.2009.06.001)
60. Melcangi RC, Magnaghi V, Galbiati M & Martini L 2001 Glial cells: a target for steroid hormones. Progress in Brain Research 132 31-40. (doi:10.1016/S0079-6123(01)32063-0)
61. Melcangi RC, Garcia-Segura LM & Mensah-Nyagan AG 2008 Neuroactive steroids: state of the art and new perspectives. Cellular and Molecular Life Sciences 65 777-797. (doi:10.1007/s00018-007-7403-5)
62. Melcangi RC, Panzica G & Garcia-Segura LM 2011 Neuroactive steroids: focus on human brain. Neuroscience 191 1-5. (doi:10.1016/ j.neuroscience.2011.06.024)
63. Melcangi RC, Caruso D, Levandis G, Abbiati F, Armentero MT & Blandini F 2012 Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease. Journal of Molecular Neuroscience 46 177-183. (doi:10.1007/s12031-011-9570-y)
64. Meyer U, Schwarz MJ & Muller N 2011 Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacology and Therapeutics 132 96-110. (doi:10.1016/j. pharmthera.2011.06.003)
65. Mills KH 2004 Regulatory T cells: friend or foe in immunity to infection? Nature Reviews. Immunology 4 841-855. (doi:10.1038/ nri1485)
66. Morgan SC, Taylor DL & Pocock JM 2004 Microglia release activators of neuronal proliferation mediated by activation of mitogenactivated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. Journal of Neurochemistry 90 89-101. (doi:10.1111/j.1471-4159.2004.02461.x)
67. Moss DW & Bates TE 2001 Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. European Journal of Neuroscience 13 529-538. (doi:10.1046/j.1460-9568.2001. 01418.x)
68. Muller FJ, Snyder EY & Loring JF 2006 Gene therapy: can neural stem cells deliver? Nature Reviews. Neuroscience 7 75-84. (doi:10.1038/ nrn1829)
69. Naylor JC, Kilts JD, Hulette CM, Steffens DC, Blazer DG, Ervin JF, Strauss JL, Allen TB, Massing MW, Payne VM et al. 2010 Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects. Biochimica et Biophysica Acta 1801 951-959. (doi:10.1016/ j.bbalip.2010.05.006)
70. Noorbakhsh F, Ellestad KK, Maingat F, Warren KG, Han MH, Steinman L, Baker GB & Power C 2011 Impaired neurosteroid synthesis in multiple sclerosis. Brain 134 2703-2721. (doi:10.1093/brain/awr200)
71. Oehmichen W & Gencic M 1975 Experimental studies on kinetics and functions of monuclear phagozytes of the central nervous system. Acta Neuropathologica (Suppl 6) 285-290.
72. Offner H 2004 Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. Journal of Neuroscience Research 78 603-624. (doi:10.1002/jnr.20330)
73. Pan Y, Zhang H, Acharya AB, Patrick PH, Oliver D & Morley JE 2005 Effect of testosterone on functional recovery in a castrate male rat stroke model. Brain Research 1043 195-204. (doi:10.1016/j.brainres. 2005.02.078)
74. Panzica GC & Melcangi RC 2008 The endocrine nervous system: source and target for neuroactive steroids. Brain Research Reviews 57 271-276. (doi:10.1016/j.brainresrev.2008.02.002)
75. Panzica GC, Balthazart J, Frye CA, Garcia-Segura LM, Herbison AE, Mensah-Nyagan AG, McCarthy MM & Melcangi RC 2012 Milestones on steroids and the nervous system: 10 years of basic and translational research. Journal of Neuroendocrinology 24 1-15. (doi:10.1111/j.1365-2826.2011.02265.x)
76. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR et al. 2006 Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends in Pharmacological Sciences 27 402-409. (doi:10.1016/j.tips.2006.06.005)
77. Pesaresi M, Giatti S, Calabrese D, Maschi O, Caruso D & Melcangi RC 2010a Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats. Journal of Molecular Neuroscience 42 135-139. (doi:10.1007/ s12031-010-9344-y)
78. Pesaresi M, Maschi O, Giatti S, Garcia-Segura LM, Caruso D & Melcangi RC 2010b Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Hormones and Behavior 57 46-55. (doi:10.1016/j.yhbeh.2009.04.008)
79. Pettus EH, Wright DW, Stein DG & Hoffman SW 2005 Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Research 1049 112-119. (doi:10.1016/j.brainres.2005.05.004)
80. Ridet JL, Malhotra SK, Privat A & Gage FH 1997 Reactive astrocytes: cellular and molecular cues to biological function. Trends in Neuroscience 20 570-577. (doi:10.1016/S0166-2236 (97)01139-9)
81. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR & Peterson PK 2004 Role of microglia in central nervous system infections. Clinical Microbiology Reviews 17 942-964. (doi:10.1128/ CMR.17.4.942-964.2004)
82. Saijo K, Collier JG, Li AC, Katzenellenbogen JA & Glass CK 2011 An ADIOL-ERb-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145 584-595. (doi:10.1016/ j.cell.2011.03.050)
83. Sawada M, Kondo N, Suzumura A & Marunouchi T 1989 Production of tumor necrosis factor-a by microglia and astrocytes in culture. Brain Research 491 394-397. (doi:10.1016/0006-8993(89) 90078-4)
84. Schumacher M, Hussain R, Gago N, Oudinet JP, Mattern C & Ghoumari AM 2012 Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Frontiers in Neuroscience 6 10. (doi:10.3389/fnins.2012.00010)
85. Schwartz M, Butovsky O, Bruck W & Hanisch UK 2006 Microglial phenotype: is the commitment reversible? Trends in Neuroscience 29 68-74. (doi:10.1016/j.tins.2005.12.005)
86. Sierra A, Gottfried-Blackmore AC, McEwen BS & Bulloch K 2007 Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55 412-424. (doi:10.1002/glia.20468)
87. Sierra A, Gottfried-Blackmore A, Milner TA, McEwen BS & Bulloch K 2008 Steroid hormone receptor expression and function in microglia. Glia 56 659-674. (doi:10.1002/glia.20644)
88. Spence RD & Voskuhl RR 2012 Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Frontiers in Neuroendocrinology 33 105-115. (doi:10.1016/j.yfrne. 2011.12.001)
89. Sun C, Ou X, Farley JM, Stockmeier C, Bigler S, Brinton RD & Wang JM 2012 Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease. Current Alzheimer Research 9 473-480.
90. Tabori NE, Stewart LS, Znamensky V, Romeo RD, Alves SE, McEwen BS & Milner TA 2005 Ultrastructural evidence that androgen receptors are located at extranuclear sites in the rat hippocampal formation. Neuroscience 130 151-163. (doi:10.1016/j.neuroscience. 2004.08.048)
91. Tansey MG 2010 Inflammation in neuropsychiatric disease. Neurobiology of Disease 37 491-492. (doi:10.1016/j.nbd.2009.12.004)
92. Tansey MG & Goldberg MS 2010 Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiology of Disease 37 510-518. (doi:10.1016/j.nbd. 2009.11.004)
93. Tansey MG, McCoy MK & Frank-Cannon TC 2007 Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Experimental Neurology 208 1-25. (doi:10.1016/j.expneurol.2007.07. 004)
94. VanLandingham JW, Cekic M, Cutler S, Hoffman SW & Stein DGCP 2007 Neurosteroids reduce inflammation after TBI through CD55 induction. Neuroscience Letters 425 94-98. (doi:10.1016/j.neulet. 2007.08.045)
95. Viviani B & Boraso MS 2011 Cytokines and neuronal channels: a molecular basis for age-related decline of neuronal function? Experimental Gerontology 46 199-206. (doi:10.1016/j.exger.2010.09.008)
96. Viviani B, Corsini E, Binaglia M, Galli CL & Marinovich M 2001 Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience 107 51-58. (doi:10.1016/ S0306-4522(01)00332-3)
97. Wang C, Dehghani B, Li Y, Kaler LJ, Vandenbark AA & Offner H 2009 Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126 329-335. (doi:10.1111/j.1365-2567.2008.03051.x)
98. Wee Yong V 2010 Inflammation in neurological disorders: a help or a hindrance? Neuroscientist 16 408-420. (doi:10.1177/ 1073858410371379)
99. Wuwongse S, Chang RC & Law AC 2010 The putative neurodegenerative links between depression and Alzheimer's disease. Progress in Neurobiology 91 362-375. (doi:10.1016/j.pneurobio.2010.04.005)
100. Yates MA, Li Y, Chlebeck P, Proctor T, Vandenbark AA &OffnerH 2010 Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 220 136-139. (doi:10.1016/j.jneuroim. 2010.01.013)